CBD Life Sciences Inc. (OTCMKTS:CBDL – Get a score) was the recipient of a significant increase in short interest during the month of July. As of July 15th, there was short interest totaling 248,200 shares, up 54.8% from the June 30th total of 160,300 shares. Based on an average daily volume of 102,336,600 shares, the short interest ratio is currently 0.0 days.
CBD Life Sciences Price Performance
CBD Life Sciences has a 12 month low of $0.00 and a 12 month high of $0.00.
About CBD Life Sciences
CBD Life Sciences Inc is engaged in the development and commercialization of a line of organic products based on cannabidiol. Their organic cannabidiol products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solution supplements, edibles, and a line of pet products. The company is headquartered in Scottsdale, Arizona.
Get news and ratings from CBD Life Sciences Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CBD Life Sciences and related companies with MarketBeat.com’s FREE daily email newsletter.